SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

13 May 2008 12:00

RNS Number : 3064U
Spirax-Sarco Engineering PLC
13 May 2008
 

Spirax-Sarco Engineering plc

Tuesday 13th May 2008 

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the four month period ended 30th April 2008, ahead of its Annual General Meeting today at 2.00 pm.

Trading

Overall market conditions have remained favourable in 2008. We have seen sustained business investment by our customers and we continue to benefit from good progress with our ongoing sales initiatives.

The organic revenue growth trend has continued from last year through into 2008. Growth was spread across all geographic regions for both the Spirax Sarco and Watson-Marlow Bredel businesses. The euro has strengthened considerably since late last year which, together with other currency movements elsewhere, has benefited the translation into sterling of total Group revenues by approximately 6% overall, with a larger benefit to operating profit.

Corporate Developments

The integration of Flexicon with our Watson-Marlow Bredel business is proceeding well following completion of the acquisition on 11th February 2008 for £14m. As previously reported, Marcus Steel retired as Chief Executive as of 31st March 2008, as did Peter Smith, Director and Company Secretary. On 1st April Mark Vernon, previously Chief Operating Officer, succeeded Marcus as Chief Executive and William Stebbings succeeded Peter as Company Secretary.

Financial position

The Group started the year with net cash of £16m and has subsequently paid an initial £11m consideration for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period and we continue to operate with a strong balance sheet. As anticipated, we expect capital expenditure this year to be well above normal levels mainly due to the new premises in China.

 

Outlook

In our preliminary statement in early March, we reported that 2008 had started well and that, assuming our global markets remained stable, we expected to produce another good performance in 2008. Trading so far this year confirms this expectation, although there remains uncertainty about the resilience of the global economy, and in particular North America. If current exchange rates prevail for the remainder of the year, sales and profits, particularly in Continental Europe, will also benefit from good exchange gains.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 521361

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBGGDUCSBGGIX
Date   Source Headline
1st Jun 20169:45 amRNSTotal Voting Rights
31st May 20165:22 pmRNSDirector Declaration
10th May 20164:48 pmRNSResult of AGM
10th May 20167:00 amRNSAGM Statement - Trading Update
6th May 20169:46 amRNSTotal Voting Rights
6th May 20169:45 amRNSHolding(s) in Company
6th May 20169:45 amRNSHolding(s) in Company
15th Apr 20162:00 pmRNSDirector/PDMR Shareholding
24th Mar 20164:38 pmRNSDirector/PDMR Shareholding
22nd Mar 201611:21 amRNSTotal Voting Rights
21st Mar 20162:15 pmRNSAnnual Report 2015 & Notice of AGM
15th Mar 201610:11 amRNSDisclosure of Home Member State
9th Mar 201612:34 pmRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results 2015
23rd Feb 201611:05 amRNSTotal Voting Rights
29th Jan 20169:10 amRNSBlocklisting Interim Review
22nd Jan 20168:21 amRNSTotal Voting Rights
6th Jan 201612:36 pmRNSHolding(s) in Company
22nd Dec 20159:27 amRNSTotal Voting Rights
8th Dec 201510:21 amRNSHolding(s) in Company
3rd Dec 201511:09 amRNSDirector/PDMR Shareholding
2nd Dec 20158:18 amRNSHolding(s) in Company
26th Nov 20152:01 pmRNSHolding(s) in Company
26th Nov 20151:58 pmRNSHolding(s) in Company
25th Nov 20159:00 amRNSAcquisition
24th Nov 20152:50 pmRNSHolding(s) in Company
23rd Nov 20151:31 pmRNSTotal Voting Rights
19th Nov 20153:18 pmRNSHolding(s) in Company
19th Nov 20153:13 pmRNSHolding(s) in Company
17th Nov 20157:00 amRNSTrading Update
10th Nov 20152:38 pmRNSDirector/PDMR Shareholding
6th Nov 20152:25 pmRNSAdditional Listing
2nd Nov 20153:27 pmRNSAdditional Listing
30th Oct 20151:20 pmRNSDirector Declaration
27th Oct 20157:00 amRNSDirectorate Change
21st Oct 20151:57 pmRNSTotal Voting Rights
13th Oct 201512:23 pmRNSDirector/PDMR Shareholding
9th Oct 201511:47 amRNSDoc re. Key Dates
9th Oct 201510:57 amRNSAdditional Listing
5th Oct 201511:47 amRNSHolding(s) in Company
28th Sep 20152:00 pmRNSAcquisition
16th Sep 201511:07 amRNSDirector/PDMR Shareholding
15th Sep 20153:42 pmRNSTotal Voting Rights - Replacement
15th Sep 20153:02 pmRNSTotal Voting Rights
9th Sep 201512:00 pmRNSCompliance with Model Code
8th Sep 201511:45 amRNSHolding(s) in Company
28th Aug 201510:18 amRNSDirector/PDMR Shareholding
26th Aug 20153:33 pmRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSHalf Year Results
4th Aug 20157:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.